Associated Papers
von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
Lethagen S et al.
Journal of Thrombosis and Haemostasis : Jth, 2007
Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study.
Federici AB et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2002
Select a paper to view details